The method of any one of embodiments 79-146, wherein the composition further comprises a mucoadhesive
Mice tolerated the treatment well throughout the study period
Given the relatively smaller reduction in body weight (9.4%) in the SELECT trial compared to previous RCTs: 14.9% in STEP1 (BMI 37.86.7 kg/m 2 ) [16] and 13.2% STEP6 (BMI 31.9 kg/m 2 ) [49], pleiotropic effects of semaglutide may contribute to the overall CV risk reduction [25,37]
Theo nghin cu khoa hc, thnh phn ny c cc tc dng chnh c th gm: 3.1
Although basal XOR expression is typically low in humans, various factors such as hypoxia, ischemia-reperfusion injury, interleukin-1 (IL-1), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-), and corticosteroid treatment can markedly enhance XOR transcription